Indomo is a clinical stage therapeutics company in the process of revolutionizing inflammatory acne treatment with the development of an at-home intradermal auto-injector. The device will provide a more accessible, cost-effective and time-efficient solution for patients seeking dermatological care. The team has improved upon the current model to incorporate a pre-filled glass syringe and provide improved usability.